Elderly heart failure patients often denied optimal treatment, study reveals

A new study in BMC Geriatrics examines how elderly heart failure patients receive guideline-directed medical therapy (GDMT). Researchers found that older adults, particularly the very elderly, often get less effective treatment than younger patients. The findings highlight gaps in care and call for better support systems to improve outcomes. The study reveals that the oldest heart failure patients frequently miss out on optimal GDMT. Clinicians sometimes hesitate to prescribe certain drugs due to concerns about polypharmacy, kidney function, or side effects in frail individuals. This caution can lead to undertreatment, increasing the risk of worsening symptoms, hospital stays, and even death.

Newer medications, such as SGLT2 inhibitors, are particularly underused in this age group. Barriers like cognitive decline, limited mobility, and weak social support further reduce adherence to prescribed treatments. Remote monitoring and telehealth could help, but many elderly patients struggle with digital tools. Researchers stress the need for age-specific clinical guidelines and more inclusive trials involving the oldest patients. They also underline the ethical duty to provide fair healthcare, regardless of age. Caregivers and social networks remain vital in helping elderly patients manage their condition effectively.

The study shows that improving GDMT adherence in elderly heart failure patients could lower hospitalisations and mortality rates. Better training for clinicians, tailored guidelines, and stronger support systems may help close the treatment gap. Without changes, older adults will continue to face unequal access to life-saving therapies.